Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

23 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Euro Pharma Articles

Bayer sees 3rd-qtr loss and settles for a "mid-size Euro pharma" image

17 November 2003

Bayer looking for Euro pharma partner?

3 October 2001

Euro Pharma constructs Indian unit

30 August 2001

Ind Euro Pharma setting up cancer unit

20 August 2001

Scotcher to lead SG Cowen pan-Euro pharma team

9 August 2001

New e-marketplace for Euro pharma trade

13 February 2001

EFPIA: Euro pharma's competitive decline

13 November 2000

Quintiles Euro pharma center for Japan firms

6 September 2000

Myriad gets $24M from Euro pharma firm

30 June 2000

More Euro pharma firms discuss plans for future growth at GS conference

24 June 1999

Paribas Investing In Euro Pharma

17 November 1998

New Euro Pharma Distribution Alliance

2 January 1995

Strategic Developments In Euro Pharma Wholesaling

1 August 1994

Strategic Developments In Euro Pharma Wholesaling

1 August 1994

US/EURO PHARMA INROADS INTO CIS

5 October 1992

Showing 1-15 of 15 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS